About
Drug Delivery System
Areas of Focus
Categories
Drug Delivery & Formulation
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
23
By Phase
PHASE1: 2EARLY_PHASE1: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06439056Lead Sponsor
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
PHASE1Completed
12 participants
Started: May 27, 2024 · Completed: Jul 18, 2025
NCT05643248Lead Sponsor
To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects
EARLY_PHASE1Completed
9 participants
Started: Nov 28, 2022 · Completed: Sep 26, 2023
NCT05048498Lead Sponsor
Pharmacokinetics, Tolerability and Safety of NEX-18a
PHASE1Completed
2 participants
Started: Apr 27, 2021 · Completed: Feb 10, 2022
Locations (1)
Headquarters
Uppsala, Sweden
Map
Loading map...